Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01976286 · ClinicalTrials.gov registry record · NA

A Pilot Study Testing Salicylic Acid Peels Versus Glycolic Acid Peels for the Treatment of Melasma

A NA study of Melanosis, sponsored by Northwestern University.

Active
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT01976286 is a NA study of Melanosis that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 21 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01976286, a NA study of Melanosis, is active but no longer recruiting, sponsored by Northwestern University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to find out the safety and effectiveness of Glycolic Acid Chemical Peels compared to Salicylic Acid Chemical Peels for the treatment of melasma.

Conditions Studied

Interventions

  • OTHER Salicylic Acid Peels
  • OTHER Glycolic Acid Peels

Study Locations (1)

Illinois

  • Northwestern University Department of Dermatology - Chicago

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2015-01
Est. Completion 2025-12
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT01976286

The ClinicalTrials.gov registry entry for NCT01976286 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Melanosis appearing as the primary indexed condition, and to 2 interventions - of which Salicylic Acid Peels is the first listed.

NCT01976286 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT01976286 about?

NCT01976286 is a clinical study titled "A Pilot Study Testing Salicylic Acid Peels Versus Glycolic Acid Peels for the Treatment of Melasma". The purpose of this study is to find out the safety and effectiveness of Glycolic Acid Chemical Peels compared to Salicylic Acid Chemical Peels for the treatment of melasma.

What is the current status of trial NCT01976286?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 21 participants. The study started on 2015-01. Estimated completion is 2025-12.

What conditions does trial NCT01976286 study?

This clinical trial studies the following conditions: Melanosis.

What interventions are being tested in trial NCT01976286?

The interventions under investigation include: Salicylic Acid Peels (OTHER), Glycolic Acid Peels (OTHER).

Who is sponsoring clinical trial NCT01976286?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01976286 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Melanosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.